Ashitaba (Angelica Keiskei) Exudate Prevents Increases in Plasminogen Activator Inhibitor-1 Induced by Obesity in Tsumura Suzuki Obese Diabetic Mice

References

• Alessi MC, Nicaud V, Scroyen I, Lange C, Saut N, Fumeron F, Marre M, Lantieri O, Fontaine-Bisson B, Juhan-Vague I, et al. 2011. Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I. R. prospective cohort. Thromb Haemost. 106:416–422. doi:10.1160/TH11-03-0179. PMID:21800006.
   PubMed Web of Science ®Google Scholar
• Alessi M, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. 1997. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes. 46:860–867. doi:10.2337/diab.46.5.860. PMID:9133556.
   PubMed Web of Science ®Google Scholar
• Baba K, Nakata K, Taniguchi M, Kido T, Kozawa K. 1990. Chalcones from Angelica keiskei. Phytochemistry. 29:3907–3910. doi:10.1016/0031-9422(90)85357-L.
   Web of Science ®Google Scholar
• Caesar LK, Cech NB. 2016. A Review of the Medicinal Uses and Pharmacology of Ashitaba. Planta Med. 82:1236–1245. doi:10.1055/s-0042-110496. PMID:27399234.
   PubMed Web of Science ®Google Scholar
• Chosich N, Rockett E, Harrison LC. 1994. Endogenous TNF production differs between high and low diabetes incidence non-obese diabetic (NOD) mice. Autoimmunity. 18:163–168. doi:10.3109/08916939409007992. PMID:7858101.
   PubMed Web of Science ®Google Scholar
• Dimova EY, Kietzmann T. 2008. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost. 100:992–1006. doi:10.1160/TH08-07-0490. PMID:19132222.
   PubMed Web of Science ®Google Scholar
• Enoki T, Ohnogi H, Nagamine K, Kudo Y, Sugiyama K, Tanabe M, Kobayashi E, Sagawa H, Kato I. 2007. Antidiabetic activities of chalcones isolated from a Japanese Herb, Angelica keiskei. J Agric Food Chem. 55:6013–6017 doi:10.1021/jf070720q. PMID:17583349.
   PubMed Web of Science ®Google Scholar
• Greyling A, Pieters M, Hoekstra T, Oosthuizen W, Schutte AE. 2007. Differences in the association of PAI-1 activity with the metabolic syndrome between African and Caucasian women. Nutr Metab Cardiovasc. 17:499–507. doi:10.1016/j.numecd.2006.04.006.
   PubMed Web of Science ®Google Scholar
• Hosokawa M, Miyashita T, Nishikawa S, Emi S, Tsukui T, Beppu F, Okada T, Miyashita K. 2010. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch Biochem Biophys. 504:17–25. doi:10.1016/j.abb.2010.05.031. PMID:20515643.
   PubMed Web of Science ®Google Scholar
• Inamori Y, Baba K, Tsujibo H, Taniguchi M, Nakata K, Kozawa M. 1991. Antibacterial activity of two chalcones, xanthoangelol and 4-hydroxyderricin, isolated from the root of Angelica keiskei KOIDZUMI. Chem Pharm Bull. (Tokyo). 39:1604–1605. doi:10.1248/cpb.39.1604. PMID:1934181.
   PubMed Web of Science ®Google Scholar
• Iwaki T, Urano T, Umemura K. 2012. PAI-1, progress in understanding the clinical problem and its aetiology. Br J Haematol. 157:291–298. doi:10.1111/j.1365-2141.2012.09074.x. PMID:22360729.
   PubMed Web of Science ®Google Scholar
• Juhan-Vague I, Alessi MC. 1997. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost. 78:656–660. PMID:9198234.
   PubMed Web of Science ®Google Scholar
• Kaji H. 2016. Adipose tissue-derived plasminogen activator inhibitor-1 function and regulation. Compr Physiol. 15:1873–1896. doi:10.1002/cphy.c160004.
   Google Scholar
• Kil YS, Pham ST, Seo EK, Jafari M. 2017. Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities. Arch Pharm Res. 40:655–675. doi:10.1007/s12272-017-0892-3. PMID:28439780.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Baba K. 2003. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol. Int J Cancer. 106:429–437. doi:10.1002/ijc.11256. PMID:12845685.
   PubMed Web of Science ®Google Scholar
• Li Y, Goto T, Ikutani R, Lin S, Takahashi N, Takahashi H, Jheng HF, Yu R, Taniguchi M, Baba K, et al. 2016. Xanthoangelol and 4-hydroxyderricin suppress obesity-induced inflammatory responses. Obesity. 24:2351–2360. doi:10.1002/oby.21611. PMID:27619735.
   PubMed Web of Science ®Google Scholar
• Marckmann P, Toubro S, Astrup A. 1998. Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects. Eur J Clin Nutr. 52:329–333. doi:10.1038/sj.ejcn.1600558. PMID:9630382.
   PubMed Web of Science ®Google Scholar
• Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, Van Gaal LF. 2006. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes. 30:1308–1314. doi:10.1038/sj.ijo.0803189.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Tokushima T, Kawabata K, Yamamoto M, Ashida H. 2012. Absorption and metabolism of 4-hydroxyderricin and xanthoangerol after oral administration of Angelica keiskei (Ashitaba) extract in mice. Arch Biochem Biophys. 521:71–76. doi:10.1016/j.abb.2012.03.013. PMID:22452965.
   PubMed Web of Science ®Google Scholar
• Nakata K, Taniguchi M, Baba K. 1999. Three chalcones from Angelica keiskei. Nat Med. 53:329–332.
   Google Scholar
• Ohkura N, Nakakuki Y, Taniguchi M, Kanai S, Nakayama A, Ohnishi K, Sakata T, Nohira T, Matsuda J, Baba K, et al. 2011. Xanthoangelols isolated from Angelica keiskei inhibit inflammatory-induced plasminogen activator inhibitor 1 (PAI-1) production. Biofactors. 37:455–461. doi:10.1002/biof.187. PMID:22038782.
   PubMed Web of Science ®Google Scholar
• Ohkura N, Ohnishi K, Taniguchi M, Nakayama A, Usuba Y, Fujita M, Fujii A, Ishibashi K, Baba K, Atsumi G. 2016. Anti-platelet effects of chalcones from Angelica keiskei Koidzumi (Ashitaba) in vivo. Die Pharmazie. 71:651–654. PMID:29441970.
   PubMed Web of Science ®Google Scholar
• Ohkura N, Shirakura M, Nakatani E, Oishi K, Atsumi G. 2012. Associations between plasma PAI-1 concentrations and its expressions in various organs in obese model mice. Thromb Res. 130:e301–e304. doi:10.1016/j.thromres.2012.08.297. PMID:23079293.
   PubMed Web of Science ®Google Scholar
• Ohkura N, Oishi K, Atsumi G. 2015. Blood coagulation and metabolic profiles in middle-aged male and female ob/ob mice. Blood Coagul Fibrinolysis. 26:522–526. doi:10.1097/MBC.0000000000000267. PMID:25692523.
   PubMed Web of Science ®Google Scholar
• Ohnogi H, Hayami S, Kudo Y, Deguchi S, Mizutani S, Enoki T, Tanimura Y, Aoi W, Naito Y, Kato I, et al. 2012. Angelica keiskei extract improves insulin resistance and hypertriglyceridemia in rats fed a high-fructose drink. Biosci Biotechnol Biochem. 76:928–932. doi:10.1271/bbb.110927. PMID:22738961.
   PubMed Web of Science ®Google Scholar
• Ohta M, Fujinami A, Kobayashi N, Amano A, Ishigami A, Tokuda H, Suzuki N, Ito F, Mori T, Sawada M, et al. 2015. Two chalcones, 4-hydroxyderricin and xanthoangelol, stimulate GLUT4-dependent glucose uptake through the LKB1/AMP-activated protein kinase signaling pathway in 3T3-L1 adipocytes. Nutr Res. 35:618–625. doi:10.1016/j.nutres.2015.05.010. PMID:26077869.
   PubMed Web of Science ®Google Scholar
• Samad F, Loskutoff DJ. 1997. The fat mouse: a powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM. Thromb Haemost. 78:652–655. PMID:9198233.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, et al. 1996. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med. 2:800–803. doi:10.1038/nm0796-800. PMID:8673927.
   PubMed Web of Science ®Google Scholar
• Son DJ, Park YO, Yu C, Lee SE, Park YH. 2014. Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidzumi). Nat Prod Res. 28:2312–2316. doi:10.1080/14786419.2014.931389. PMID:25019280.
   PubMed Web of Science ®Google Scholar
• Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, Sato T, Endo T, Kawamura H. 1999. A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim. 48:181–189. doi:10.1538/expanim.48.181. PMID:10480023.
   PubMed Web of Science ®Google Scholar
• Tsuneyama K, Nishitsuji K, Matsumoto M, Kobayashi T, Morimoto Y, Tsunematsu T, Ogawa H. 2017. Animal models for analyzing metabolic syndrome-associated liver diseases. Pathol Int. 67:539–546. doi:10.1111/pin.12600.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Takeshita K, Saito H. 2014. Plasminogen activator inhibitor-1 in aging. Semin Thromb Hemost. 40:652–659. doi:10.1055/s-0034-1384635.
   PubMed Web of Science ®Google Scholar